The Take 5 Campaign: Effects of an Intervention to Promote Five-Day Durations of Antibiotic Therapy for Common Infections in Urgent Care
Abstract
Abstract Background We implemented an intervention to promote 5-day durations of antibiotic therapy for common infections in urgent care. The objectives of this study were to evaluate the effects of this intervention on prescribed durations and clinical outcomes. Methods This was a quasi-experimental study involving 2 urgent care centers in an integrated health care system. The Take 5 campaign was a multifaceted intervention to promote adherence to institutional guidance for 5-day durations of therapy for skin infections, urinary tract infections, sinusitis, otitis media, pneumonia, and chronic obstructive pulmonary disease exacerbations. Patients ≥18 years of age with an urgent care visit between January 2017 and December 2023 for 1 of the target infections were included. The primary outcome was the proportion of antibiotic prescriptions for ≤5 days before and after the intervention, as assessed by interrupted time-series analysis (ITS). Results Before the intervention, there was a significant increasing trend in the proportion of prescriptions for ≤5 days. The intervention was associated with an immediate 10.7% increase in the proportion of prescriptions for ≤5 days (P < .001), with a subsequent sustained upward trend of 0.18% per month (P < .001). The aggregate proportion of prescriptions for ≤5 days increased from 57.5% before the intervention to 82.9% after implementation (P < .001). Rates of new antibiotic prescriptions and hospitalizations within 14 days were similar…
Read the paper
Related studies
- Impact of antibiotics on the human microbiome and consequences for host health
- Antibiotics in the clinical pipeline in October 2019
- The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan
- Research Communications of the 32nd ECVIM-CA Online Congress
- Singlet-Oxygen Therapy. Scientific And Methodological Materials
- Artificial Intelligence in Pharmacovigilance
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.